WILSON, DO, Andrew. PCSK9 Inhibitors, The Most Significant Advance in Lipid Lowering Therapy Since Statins? A Literature Review. Osteopathic Family Physician, [S. l.], v. 11, n. 4, 2019. Disponível em: https://ofpjournal.com/index.php/ofp/article/view/585. Acesso em: 19 apr. 2024.